Beast Ventures
VC Fund
London, United Kingdom
Beast Ventures is a venture capital firm
- Total investments:
- 8
- Last investment:
- Lead investor:
- 13%
Last updated:
For AI agents: llms.txt
Industries Beast Ventures invests in
Stages Beast Ventures invests in
Countries Beast Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Biotechnology 5 (63%)
- Robotics 2 (25%)
- Health Care 2 (25%)
- Life Science 2 (25%)
- Machine Learning 2 (25%)
Stage
- Seed 3 (38%)
- Series B 2 (25%)
- Pre-Seed 1 (13%)
- Series A 1 (13%)
- Venture - Series Unknown 1 (13%)
Country
- United Kingdom 3 (38%)
- United States 2 (25%)
- France 1 (13%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Patrick Schneider-Sikorsky
Partner and Founder
|
Partner and Founder | Total investments: 7 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Baseimmune is a biotech startup founded to create the next generation of vaccines. | $11.4M / Series A / Feb 26, 2024 | ||
| Nutropy produces real milk ingredients, identical to those produced by cows, to develop premium cheese alternatives that taste just as good as cow’s cheese but are more sustainable, healthier and better for the animals. No animals involved, full cheese experience. | $2M / Pre-Seed / Sep 12, 2022 | ||
| Baseimmune is a biotech startup founded to create the next generation of vaccines. | $4.8M / Seed / Nov 02, 2021 | ||
| Q Bio was founded in 2015 by Jeffrey Kaditz, serial entrepreneur and Founder of Affirm, Dr Michael Snyder, Chair of Genetics and Director of Personalized Medicine and Stanford University, and Dr Garry Choy, physician, radiologist, and former Chief Medical Information Officer at Mass General Hospital. Q Bio is fortunate to be backed by some of thebest venture groups in the world including: A16Z, Khosla Ventures, Founders Fund, SciFi VC, and Kevin Durant. This interdisciplinary team based in San Carlos, CA is comprised of pioneers in fields such applied math, computational physics, electrical engineering, genetics, and radiology, hail from a dizzying array of home countries and cultural backgrounds. | $40M / Series B / Feb 20, 2020 | ||
| Clear Labs harnesses the power of next-generation sequencing (NGS) to simplify complex diagnostics for clinical and applied markets. By creating a fully automated platform that brings together DNA sequencing, robotics, and cloud-based analytics, Clear Labs democratizes genomics applications to deliver increased clarity.Clear Labs’ turnkeyplatform accelerates outcomes and improves accuracy - from food-borne pathogens to infectious diseases, including SARS CoV-2. With a novel approach, Clear Labs is helping the world better understand, track, and mitigate tomorrow’s novel pathogens. | $21M / Series B / Oct 30, 2018 | ||
| LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine. Its protein engineering platform integrates several bleeding-edge technologies from the fields of machine learning, synthetic biology, and robotics. | $3.7M / Seed / Nov 24, 2017 | ||
| Sparrho is a world leader in making science accessible to build trust in brands. They achieve this using their unique combination of AI and PhD experts, which they call Augmented Intelligence.Sparrho was founded in 2013 out of frustration with existing literature search tools by two Oxbridge scientists, and now has a growing and tightly knit teambased in London, UK.Today Sparrho caters to Fortune 500 companies across the globe. Their platform uses augmented intelligence to aggregate, curate and summarise the latest in scientific research. | $3M / Venture - Series Unknown / Jul 10, 2017 | ||
| Q Bio was founded in 2015 by Jeffrey Kaditz, serial entrepreneur and Founder of Affirm, Dr Michael Snyder, Chair of Genetics and Director of Personalized Medicine and Stanford University, and Dr Garry Choy, physician, radiologist, and former Chief Medical Information Officer at Mass General Hospital. Q Bio is fortunate to be backed by some of thebest venture groups in the world including: A16Z, Khosla Ventures, Founders Fund, SciFi VC, and Kevin Durant. This interdisciplinary team based in San Carlos, CA is comprised of pioneers in fields such applied math, computational physics, electrical engineering, genetics, and radiology, hail from a dizzying array of home countries and cultural backgrounds. | $7.5M / Seed / Jan 01, 2016 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Beast Ventures invest in?
Beast Ventures invests primarily in Biotechnology, Robotics and Health Care startups, most often at Seed and Series B stage. Most of the 8 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Beast Ventures?
Public channels for Beast Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Beast Ventures?
The team at Beast Ventures includes Patrick Schneider-Sikorsky (Partner and Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
